Pancreatic Cancer Research

ResearcherLoyola University Medical CenterNo recent work listed

Melissa R. Junttila

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3538-1192; OpenAlex author ID A5040110214. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2015: 2 papers

Papers 2

  1. Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-14-0030↗
  2. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer. First author DOI 10.1200/jco.2015.62.8719↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Klaus P. Hoeflich · 1 shared paper, 2015 · strength 0.04
  2. Mallika Singh · 1 shared paper, 2015 · strength 0.04
  3. Deirdre Jill Cohen · 1 shared paper, 2015 · strength 0.04
  4. Robert Marsh · 1 shared paper, 2015 · strength 0.04
  5. Heinz‐Josef Lenz · 1 shared paper, 2015 · strength 0.04
  6. Daniel V.T. Catenacci · 1 shared paper, 2015 · strength 0.04
  7. Hedy Lee Kindler · 1 shared paper, 2015 · strength 0.04
  8. Nathan Bahary · 1 shared paper, 2015 · strength 0.04
  9. Ravi Salgia · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.